A significant dilemma in the treatment of heart failure patients with sacubitril/valsartan or sodium-glucose co-transporter 2 inhibitors: Whether to add mineralocorticoid receptor antagonists
Rev Port Cardiol. 2022 Aug;41(8):705-707.
doi: 10.1016/j.repc.2021.10.009.
Epub 2022 May 27.
[Article in
English,
Portuguese]
Affiliations
- 1 Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration", Greece. Electronic address: dipatoulias@gmail.com.
- 2 Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital "Hippokration", Greece.
- 3 Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration", Greece.
- 4 Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration", Greece; Veterans Affairs Medical Center, George Washington University, Washington, District of Columbia, United States.
No abstract available